Angina After PCI: a Systems Medicine Study

Enrolling by invitationOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

October 1, 2028

Conditions
Angina (Stable)Ischemic Heart Disease (IHD)
Interventions
DIAGNOSTIC_TEST

Cardiovascular magnetic resonance imaging

Observational diagnostic tests will include adenosine-stress perfusion cardiovascular magnetic resonance imaging before undergoing percutaneous coronary intervention.

DIAGNOSTIC_TEST

Coronary physiology

Invasive coronary function tests using a diagnostic guidewire (PressureWire-X, Abbott), thermodilution, intravenous or intracoronary infusion of adenosine and intracoronary infusions of acetylcholine.

Trial Locations (4)

CB20AY

Royal Papworth Hospital NHS Foundation Trust, Cambridge

G814DY

Golden Jubilee National Hospital, Clydebank

G75 8RG

University Hospital Hairmyres, East Kilbride

LS13EX

Leeds General Infirmary, Leeds

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Robertson Centre for Biostatistics - University of Glasgow

UNKNOWN

collaborator

British Heart Foundation

OTHER

collaborator

Abbott Medical Devices

INDUSTRY

collaborator

CoreAalst BV

INDUSTRY

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

NHS National Waiting Times Centre Board

OTHER

NCT06854302 - Angina After PCI: a Systems Medicine Study | Biotech Hunter | Biotech Hunter